
### [MONDO:0016388](http://purl.obolibrary.org/obo/MONDO_0016388)
**Label:** bone sarcoma

**Subclasses:** [MONDO:0012817](http://purl.obolibrary.org/obo/MONDO_0012817) (Ewing sarcoma), [MONDO:0017046](http://purl.obolibrary.org/obo/MONDO_0017046) (neuroepithelioma), [MONDO:0002629](http://purl.obolibrary.org/obo/MONDO_0002629) (bone osteosarcoma), [MONDO:0007300](http://purl.obolibrary.org/obo/MONDO_0007300) (cerebral sarcoma), [MONDO:0016069](http://purl.obolibrary.org/obo/MONDO_0016069) (undifferentiated pleomorphic sarcoma), [MONDO:0005164](http://purl.obolibrary.org/obo/MONDO_0005164) (fibrosarcoma (disease)), [MONDO:0011934](http://purl.obolibrary.org/obo/MONDO_0011934) (dermatofibrosarcoma protuberans), [MONDO:0018271](http://purl.obolibrary.org/obo/MONDO_0018271) (peripheral primitive neuroectodermal tumor), [MONDO:0018219](http://purl.obolibrary.org/obo/MONDO_0018219) (giant cell tumor of bone (disease)), 

**Corr. equiv. classes:** [Orphanet:2677](http://www.orpha.net/ORDO/Orphanet_2677), [Orphanet:31112](http://www.orpha.net/ORDO/Orphanet_31112), [Orphanet:2023](http://www.orpha.net/ORDO/Orphanet_2023), [Orphanet:2030](http://www.orpha.net/ORDO/Orphanet_2030), [Orphanet:668](http://www.orpha.net/ORDO/Orphanet_668), [Orphanet:319](http://www.orpha.net/ORDO/Orphanet_319), [OMIM:612219](http://purl.obolibrary.org/obo/OMIM_612219), [OMIM:117600](http://purl.obolibrary.org/obo/OMIM_117600), [OMIM:607907](http://purl.obolibrary.org/obo/OMIM_607907), [OMIM:259500](http://purl.obolibrary.org/obo/OMIM_259500), [Orphanet:363976](http://www.orpha.net/ORDO/Orphanet_363976), [Orphanet:370348](http://www.orpha.net/ORDO/Orphanet_370348), 

**Class expressions from DL-Learner:**

- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 25.40%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) 25.34%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000019](http://purl.obolibrary.org/obo/HP_0000019) (Urinary hesitancy))) 25.34%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000018](http://purl.obolibrary.org/obo/HP_0000018) (null))) 25.34%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 25.34%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 25.34%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 25.34%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 25.34%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 25.34%
- [HP:0100242](http://purl.obolibrary.org/obo/HP_0100242) (Sarcoma) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 25.34%
- [HP:0011792](http://purl.obolibrary.org/obo/HP_0011792) (Neoplasm by histology) 22.66%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 21.97%
- Thing 21.97%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 21.97%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 19.89%


